Yeast Infection Treatment Global Market Report 2025

Description

Yeast infection treatment refers to medications utilized to address infections resulting from Candida fungus overgrowth, commonly known as yeast infections or candidiasis. These infections can manifest in various body parts such as the mouth (oral thrush), genitals (vaginal yeast infection), skin, and mucous membranes. The treatments aim to alleviate yeast infection symptoms.

Yeast infection treatment come in different forms such as powders, creams, ointments, tablets, or capsules, and can involve medical treatment or surgery. Indications for these treatments include genital candidiasis, invasive candidiasis, oropharyngeal or esophageal candidiasis (thrush), among others. Administration routes include oral, topical, IV (intravenous), or IM (intramuscular), and the treatments are utilized across various applications such as retail pharmacies, hospital pharmacies, specialty stores, online sales, and more.

The yeast infection treatment market research report is one of a series of new reports from The Business Research Company that provides yeast infection treatment market statistics, including yeast infection treatment industry global market size, regional shares, competitors with a yeast infection treatment market share, detailed yeast infection treatment market segments, market trends and opportunities, and any further data you may need to thrive in the yeast infection treatment industry. This yeast infection treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The yeast infection treatment market size has grown strongly in recent years. It will grow from $4.33 billion in 2024 to $4.65 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increased prevalence of yeast infections, growing awareness about fungal infections, aging population, rise in healthcare expenditure globally, and development and approval of new antifungal medications.

The yeast infection treatment market size is expected to see strong growth in the next few years. It will grow to $5.85 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to increasing adoption of telemedicine for remote consultations, personalized medicine approaches for targeted treatment, emergence of combination therapies for enhanced efficacy, growing emphasis on natural and herbal remedies, and focus on microbiome-based therapies for infection management. Major trends in the forecast period include advancements in genomic research, development of compact and accurate diagnostic equipment, technological advancements in the field of yeast infection diagnosis and treatment, increasing investments in research and development, and strategic partnerships.

The anticipated increase in autoimmune disease prevalence is forecasted to drive the expansion of the yeast infection treatment market in the foreseeable future. Autoimmune diseases involve the immune system mistakenly attacking healthy cells, tissues, and organs, leading to weakened bodily functions and potentially life-threatening complications. Yeast infection treatments play a crucial role in managing and preventing autoimmune disease complications by addressing recurrent yeast infections associated with certain autoimmune syndromes. Additionally, they may modulate the immune response by managing fungal infections in patients with autoimmune conditions. For instance, as of March 2023, the National Institutes of Health reported an estimated 8.4 million global cases of type 1 diabetes (T1DM) in 2021, with 500,000 new cases reported that year. Projections indicate the T1DM population to reach between 13.5 and 17.4 million by 2040. Hence, the increasing prevalence of autoimmune diseases is fostering the growth of the yeast infection treatment market.

Key players in the yeast infection treatment market are concentrating on introducing innovative solutions, such as non-azole oral antifungals, to enhance their competitive position. A non-azole oral antifungal is a medication designed to combat fungal infections without belonging to the azole class. For instance, in December 2022, SCYNEXIS, a US-based biotechnology company, received approval from the United States Food and Drug Administration (FDA) for BREXAFEMME (ibrexafungerp tablets), marking its second indication. BREXAFEMME is a pioneering non-azole oral antifungal, the first FDA-endorsed therapy for treating vaginal yeast infections (vulvovaginal candidiasis, VVC) and reducing the recurrence of VVC. With its broad-spectrum activity, BREXAFEMME provides a novel alternative, addressing the limited treatment options for patients with recurrent VVC and reshaping the yeast infection treatment market landscape. The recommended dosage of BREXAFEMME for VVC treatment is 300 mg (two 150 mg tablets) administered one day apart, totaling 600 mg (four 150 mg tablets) daily.

In March 2023, GlaxoSmithKline Plc, a UK-based biopharma company, entered into a partnership with Scynexis to advance the development of Brexafemme (isavuconazonium sulfate) for treating vaginal yeast infections. Through this collaboration, the availability and accessibility of this innovative treatment are expected to be significantly enhanced, providing substantial benefits for patients with challenging infections caused by resistant fungi. Scynexis, a US-based biotechnology company, specializes in creating innovative therapies for hard-to-treat infections, with a primary focus on fungal infections.

Major companies operating in the yeast infection treatment market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis International AG, Sanofi SA, Thermo Fisher Scientific Inc., Abbott Laboratories, AstraZeneca PLC, Bayer AG, Astellas Pharma Inc., Torrent Pharmaceuticals, Catalent Inc., bioMerieux SA, Cipla, Bruker Corporation, Brundavan Laboratories Private Limited, Glenmark Pharmaceuticals Ltd, Zydus Lifesciences, Prestige Consumer Healthcare Inc., CordenPharma International, Synmedic Laboratories, Basilea Pharmaceutica AG, Jubilant Pharmova Limited, Curia Global Inc., Synexis LLC, Manus Aktteva Biopharma LLP

North America was the largest region in the yeast infection treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yeast infection treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the yeast infection treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The yeast infection treatment market consists of revenues earned by entities by providing diagnostic testing, personalized treatment plans, telemedicine consultations, educational programs and more. The market value includes the value of related goods sold by the service provider or included within the service offering. The yeast infection treatment market also includes sales of miconazole, terconazole, fluconazole, amphotericin B, itraconazole, and caspofungin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Yeast Infection Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on yeast infection treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for yeast infection treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The yeast infection treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Powders; Creams Or Ointments; Tablets Or Capsules; Other Types
2) By Treatment: Medical Treatment; Surgery
3) By Indication: Genital Candidiasis; Invasive Candidiasis; Oropharyngeal Or Esophageal Candidiasis (Thrush); Other Indications
4) By Route Of Administration: Oral; Topical; IV (Intravenous) Or IM (Intramuscular); Other Routes Of Administration
5) By Application: Retail Pharmacies Or Drug Stores; Hospital Pharmacies; Specialty Stores; Online Sales; Other Applications
Subsegments:
1) By Powders: Antifungal Powders; Medicated Body Powders
2) By Creams Or Ointments: Antifungal Creams; Vaginal Ointments; Topical Creams
3) By Tablets Or Capsules: Oral Antifungal Tablets; Probiotic Capsules; Vaginal Tablets
4) By Other Types: Suppositories; Sprays; Gels
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Novartis International AG; Sanofi SA
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r29306

1. Executive Summary

2. Yeast Infection Treatment Market Characteristics

3. Yeast Infection Treatment Market Trends And Strategies

4. Yeast Infection Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Yeast Infection Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Yeast Infection Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Yeast Infection Treatment Market Growth Rate Analysis
5.4. Global Yeast Infection Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Yeast Infection Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Yeast Infection Treatment Total Addressable Market (TAM)

6. Yeast Infection Treatment Market Segmentation

6.1. Global Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Powders
Creams Or Ointments
Tablets Or Capsules
Other Types
6.2. Global Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medical Treatment
Surgery
6.3. Global Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genital Candidiasis
Invasive Candidiasis
Oropharyngeal Or Esophageal Candidiasis (Thrush)
Other Indications
6.4. Global Yeast Infection Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Topical
IV (Intravenous) Or IM (Intramuscular)
Other Routes Of Administration
6.5. Global Yeast Infection Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Retail Pharmacies Or Drug Stores
Hospital Pharmacies
Specialty Stores
Online Sales
Other Applications
6.6. Global Yeast Infection Treatment Market, Sub-Segmentation Of Powders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antifungal Powders
Medicated Body Powders
6.7. Global Yeast Infection Treatment Market, Sub-Segmentation Of Creams Or Ointments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antifungal Creams
Vaginal Ointments
Topical Creams
6.8. Global Yeast Infection Treatment Market, Sub-Segmentation Of Tablets Or Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Antifungal Tablets
Probiotic Capsules
Vaginal Tablets
6.9. Global Yeast Infection Treatment Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Suppositories
Sprays
Gels

7. Yeast Infection Treatment Market Regional And Country Analysis

7.1. Global Yeast Infection Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Yeast Infection Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Yeast Infection Treatment Market

8.1. Asia-Pacific Yeast Infection Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Yeast Infection Treatment Market

9.1. China Yeast Infection Treatment Market Overview
9.2. China Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Yeast Infection Treatment Market

10.1. India Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Yeast Infection Treatment Market

11.1. Japan Yeast Infection Treatment Market Overview
11.2. Japan Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Yeast Infection Treatment Market

12.1. Australia Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Yeast Infection Treatment Market

13.1. Indonesia Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Yeast Infection Treatment Market

14.1. South Korea Yeast Infection Treatment Market Overview
14.2. South Korea Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Yeast Infection Treatment Market

15.1. Western Europe Yeast Infection Treatment Market Overview
15.2. Western Europe Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Yeast Infection Treatment Market

16.1. UK Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Yeast Infection Treatment Market

17.1. Germany Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Yeast Infection Treatment Market

18.1. France Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Yeast Infection Treatment Market

19.1. Italy Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Yeast Infection Treatment Market

20.1. Spain Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Yeast Infection Treatment Market

21.1. Eastern Europe Yeast Infection Treatment Market Overview
21.2. Eastern Europe Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Yeast Infection Treatment Market

22.1. Russia Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Yeast Infection Treatment Market

23.1. North America Yeast Infection Treatment Market Overview
23.2. North America Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Yeast Infection Treatment Market

24.1. USA Yeast Infection Treatment Market Overview
24.2. USA Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Yeast Infection Treatment Market

25.1. Canada Yeast Infection Treatment Market Overview
25.2. Canada Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Yeast Infection Treatment Market

26.1. South America Yeast Infection Treatment Market Overview
26.2. South America Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Yeast Infection Treatment Market

27.1. Brazil Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Yeast Infection Treatment Market

28.1. Middle East Yeast Infection Treatment Market Overview
28.2. Middle East Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Yeast Infection Treatment Market

29.1. Africa Yeast Infection Treatment Market Overview
29.2. Africa Yeast Infection Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Yeast Infection Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Yeast Infection Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Yeast Infection Treatment Market Competitive Landscape And Company Profiles

30.1. Yeast Infection Treatment Market Competitive Landscape
30.2. Yeast Infection Treatment Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

31. Yeast Infection Treatment Market Other Major And Innovative Companies

31.1. Thermo Fisher Scientific Inc.
31.2. Abbott Laboratories
31.3. AstraZeneca PLC
31.4. Bayer AG
31.5. Astellas Pharma Inc.
31.6. Torrent Pharmaceuticals
31.7. Catalent Inc.
31.8. bioMerieux SA
31.9. Cipla
31.10. Bruker Corporation
31.11. Brundavan Laboratories Private Limited
31.12. Glenmark Pharmaceuticals Ltd
31.13. Zydus Lifesciences
31.14. Prestige Consumer Healthcare Inc.
31.15. CordenPharma International

32. Global Yeast Infection Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Yeast Infection Treatment Market

34. Recent Developments In The Yeast Infection Treatment Market

35. Yeast Infection Treatment Market High Potential Countries, Segments and Strategies

35.1 Yeast Infection Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Yeast Infection Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Yeast Infection Treatment Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer